The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.

@article{Zheng2007TheEA,
  title={The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.},
  author={Jin-ping Zheng and Lan Yang and Ya Mei Wu and Ping Chen and Zhong Guang Wen and Wen-jie Huang and Yi Shi and Changzheng Wang and Shao-guang Huang and Tie-ying Sun and Guang-fa Wang and Sheng-dao Xiong and Nan-shan Zhong},
  journal={Chest},
  year={2007},
  volume={132 6},
  pages={1756-63}
}
BACKGROUND Few studies of the efficacy and safety of therapy with combinations of salmeterol/fluticasone propionate (SFCs) have been conducted in Chinese patients with COPD, and the benefits of combination therapy in nonsmoking patients with COPD are, to our knowledge, not known. STUDY OBJECTIVES The aims were to establish the efficacy and tolerability of the therapy with SFC (salmeterol, 50 microg/fluticasone, 500 microg, twice daily) in the management of Chinese COPD patients and to… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

Similar Papers

Loading similar papers…